Kestra Medical Technologies 与 Biobeat Technologies 达成战略合作，旨在提升心脏康复期间可穿戴除颤器患者的诊断洞察力

美股速递01-13

Kestra Medical Technologies Inc (以下简称Kestra) 近日宣布，已与 Biobeat Technologies 建立战略合作关系。此次合作的核心目标，是通过整合双方的前沿技术，显著拓展针对正处于心脏康复期的可穿戴除颤器患者的诊断数据与临床洞察。

这一举措旨在为患者提供更全面、更连续的生理监测，从而优化其康复路径的管理。通过结合Kestra在可穿戴除颤器领域的专业优势与Biobeat先进的监测技术，双方期望能够为临床医生提供更深入、更及时的患者健康状况信息，最终改善患者的治疗结果。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1123025838?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-13 19:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123025838","market":"us","top_or_hot":-1,"title":"Kestra Medical Technologies 与 Biobeat Technologies 达成战略合作，旨在提升心脏康复期间可穿戴除颤器患者的诊断洞察力","media":"美股速递","content":"<p>Kestra Medical Technologies Inc (以下简称Kestra) 近日宣布，已与 Biobeat Technologies 建立战略合作关系。此次合作的核心目标，是通过整合双方的前沿技术，显著拓展针对正处于心脏康复期的可穿戴除颤器患者的诊断数据与临床洞察。</p>\n<p>这一举措旨在为患者提供更全面、更连续的生理监测，从而优化其康复路径的管理。通过结合Kestra在可穿戴除颤器领域的专业优势与Biobeat先进的监测技术，双方期望能够为临床医生提供更深入、更及时的患者健康状况信息，最终改善患者的治疗结果。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kestra Medical Technologies 与 Biobeat Technologies 达成战略合作，旨在提升心脏康复期间可穿戴除颤器患者的诊断洞察力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKestra Medical Technologies 与 Biobeat Technologies 达成战略合作，旨在提升心脏康复期间可穿戴除颤器患者的诊断洞察力\n</h2>\n\n<h4 class=\"meta\">\n\n2026-01-13 19:06 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Kestra Medical Technologies Inc (以下简称Kestra) 近日宣布，已与 Biobeat Technologies 建立战略合作关系。此次合作的核心目标，是通过整合双方的前沿技术，显著拓展针对正处于心脏康复期的可穿戴除颤器患者的诊断数据与临床洞察。\n这一举措旨在为患者提供更全面、更连续的生理监测，从而优化其康复路径的管理。通过结合Kestra在可穿戴除颤器领域的专业...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KMTS","symbol_name":"Kestra Medical Technologies Inc","start_time":0,"source_url":"","article_id":"1123025838","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123025838","pubTimestamp":1768302375,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Kestra Medical Technologies Inc (以下简称Kestra) 近日宣布，已与 Biobeat Technologies 建立战略合作关系。此次合作的核心目标，是通过整合双方的前沿技术，显著拓展针对正处于心脏康复期的可穿戴除颤器患者的诊断数据与临床洞察。\n这一举措旨在为患者提供更全面、更连续的生理监测，从而优化其康复路径的管理。通过结合Kestra在可穿戴除颤器领域的专业优势与Biobeat先进的监测技术，双方期望能够为临床医生提供更深入、更及时的患者健康状况信息，最终改善患者的治疗结果。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"KMTS":"Kestra Medical Technologies Inc","BK4082":"医疗保健设备"},"translate_title":"Kestra Medical Technologies and Biobeat Technologies Enter Strategic Partnership to Enhance Diagnostic Insights for Wearable Defibrillator Patients During Cardiac Rehabilitation","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KMTS":1},"content_text":"Kestra Medical Technologies Inc (以下简称Kestra) 近日宣布，已与 Biobeat Technologies 建立战略合作关系。此次合作的核心目标，是通过整合双方的前沿技术，显著拓展针对正处于心脏康复期的可穿戴除颤器患者的诊断数据与临床洞察。\n这一举措旨在为患者提供更全面、更连续的生理监测，从而优化其康复路径的管理。通过结合Kestra在可穿戴除颤器领域的专业优势与Biobeat先进的监测技术，双方期望能够为临床医生提供更深入、更及时的患者健康状况信息，最终改善患者的治疗结果。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123025838","isCrawlerRequest":true}